Sumo announced FY18 figures today that revealed better than expected organic, cfx sales growth of 31% year on year and adj. EBITDA that was slightly ahead of our (and consensus) expectations. Adjusted sales were £38.9m vs Zeus/cons. £37.3m/£36.5m, adj. EBITDA was £10.4m Vs Zeus and cons. at £10.3m and adj. PBT was £9.04m Vs Zeus and cons. of £9.1m. The quoted adj EPS, per the press release was 5.6p (basic) but using a lower tax charge than we modelled
09 Apr 2019
FY18 slightly ahead. Organic sales growth 31%
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
FY18 slightly ahead. Organic sales growth 31%
- Published:
09 Apr 2019 -
Author:
Bob Liao, CFA -
Pages:
6
Sumo announced FY18 figures today that revealed better than expected organic, cfx sales growth of 31% year on year and adj. EBITDA that was slightly ahead of our (and consensus) expectations. Adjusted sales were £38.9m vs Zeus/cons. £37.3m/£36.5m, adj. EBITDA was £10.4m Vs Zeus and cons. at £10.3m and adj. PBT was £9.04m Vs Zeus and cons. of £9.1m. The quoted adj EPS, per the press release was 5.6p (basic) but using a lower tax charge than we modelled